Global AI Biomedicine Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global AI Biomedicine Service market size was valued at US$ 4253 million in 2025 and is forecast to a readjusted size of US$ 7704 million by 2032 with a CAGR of 8.8% during review period.
AI biomedicine service represents the deep application of artificial intelligence technology in the biomedical field, aiming to accelerate new drug development, optimize disease diagnosis and treatment plans through advanced technologies such as big data analysis and machine learning. This service encompasses multiple aspects, from drug discovery and clinical trial design to patient management, significantly improving the efficiency and accuracy of biomedical research and development. By deeply mining massive medical data, ai can identify potential biomarkers, predict disease progression, and provide personalized treatment plans for patients. Additionally, ai assists doctors in diagnosing complex diseases, reducing misdiagnosis rates, and enhancing the quality of medical services. With continuous technological advancements, ai biomedicine service is gradually transforming the landscape of the biomedical industry, bringing more health benefits to patients.
From a multi-dimensional classification and parameterization perspective, the market can be segmented by service focus (AI drug discovery, AI antibody/biologic discovery, AI pathology and biomarker services, AI omics analytics), by delivery model (platform-as-a-service, fee-for-service, co-development partnerships, or risk-sharing milestone models), and by data modality (chemical structures, protein structures, imaging pathology data, genomics, transcriptomics, and multi-omics). Key performance parameters used by customers include hit identification success rates, lead optimization cycles, reduction in wet-lab iterations, model generalizability across targets, and the ability to integrate proprietary datasets securely.
The industry value chain begins upstream with data generation sources such as high-throughput screening labs, biobanks, sequencing providers, and pathology laboratories, alongside cloud and computing infrastructure suppliers. Midstream players are AI Biomedicine Service providers that combine proprietary algorithms, curated datasets, and domain expertise to deliver discovery or analysis services. Downstream customers include pharmaceutical companies, biotech startups, and, increasingly, CROs and CDMOs integrating AI into their service portfolios. Strategic partnerships and long-term collaborations are common, often embedding AI services deeply into clients? R&D workflows.
From a profitability perspective, AI Biomedicine Services generally exhibit attractive gross margins, typically in the 60?80% range, reflecting their software- and data-driven nature. Margins vary by model: platform subscriptions and recurring service contracts achieve higher margins, while project-based discovery services see lower margins due to scientific labor and validation costs. Market momentum is driven by rising R&D costs, pressure to improve pipeline productivity, and growing acceptance of AI-derived insights by regulators and pharma partners. Key trends include consolidation between AI platforms and CROs, expansion from discovery into preclinical and translational stages, and increasing use of outcome-linked and co-development revenue models.
This report is a detailed and comprehensive analysis for global AI Biomedicine Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Biomedicine Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Biomedicine Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Biomedicine Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Biomedicine Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Biomedicine Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe AI Biomedicine Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Biomedicine Service, with revenue, gross margin, and global market share of AI Biomedicine Service from 2021 to 2026.
Chapter 3, the AI Biomedicine Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Biomedicine Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Biomedicine Service.
Chapter 13, to describe AI Biomedicine Service research findings and conclusion.
AI biomedicine service represents the deep application of artificial intelligence technology in the biomedical field, aiming to accelerate new drug development, optimize disease diagnosis and treatment plans through advanced technologies such as big data analysis and machine learning. This service encompasses multiple aspects, from drug discovery and clinical trial design to patient management, significantly improving the efficiency and accuracy of biomedical research and development. By deeply mining massive medical data, ai can identify potential biomarkers, predict disease progression, and provide personalized treatment plans for patients. Additionally, ai assists doctors in diagnosing complex diseases, reducing misdiagnosis rates, and enhancing the quality of medical services. With continuous technological advancements, ai biomedicine service is gradually transforming the landscape of the biomedical industry, bringing more health benefits to patients.
From a multi-dimensional classification and parameterization perspective, the market can be segmented by service focus (AI drug discovery, AI antibody/biologic discovery, AI pathology and biomarker services, AI omics analytics), by delivery model (platform-as-a-service, fee-for-service, co-development partnerships, or risk-sharing milestone models), and by data modality (chemical structures, protein structures, imaging pathology data, genomics, transcriptomics, and multi-omics). Key performance parameters used by customers include hit identification success rates, lead optimization cycles, reduction in wet-lab iterations, model generalizability across targets, and the ability to integrate proprietary datasets securely.
The industry value chain begins upstream with data generation sources such as high-throughput screening labs, biobanks, sequencing providers, and pathology laboratories, alongside cloud and computing infrastructure suppliers. Midstream players are AI Biomedicine Service providers that combine proprietary algorithms, curated datasets, and domain expertise to deliver discovery or analysis services. Downstream customers include pharmaceutical companies, biotech startups, and, increasingly, CROs and CDMOs integrating AI into their service portfolios. Strategic partnerships and long-term collaborations are common, often embedding AI services deeply into clients? R&D workflows.
From a profitability perspective, AI Biomedicine Services generally exhibit attractive gross margins, typically in the 60?80% range, reflecting their software- and data-driven nature. Margins vary by model: platform subscriptions and recurring service contracts achieve higher margins, while project-based discovery services see lower margins due to scientific labor and validation costs. Market momentum is driven by rising R&D costs, pressure to improve pipeline productivity, and growing acceptance of AI-derived insights by regulators and pharma partners. Key trends include consolidation between AI platforms and CROs, expansion from discovery into preclinical and translational stages, and increasing use of outcome-linked and co-development revenue models.
This report is a detailed and comprehensive analysis for global AI Biomedicine Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Biomedicine Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Biomedicine Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Biomedicine Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Biomedicine Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Biomedicine Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- AI-driven Drug Discovery Services
- AI-based Preclinical Research Services
- AI-enabled Clinical Trial Services
- AI Biomarker & Companion Diagnostic Services
- Others
- Genomics & Multi-omics AI Services
- Medical Imaging & Digital Pathology AI Services
- Chemical & Molecular Structure AI Services
- Clinical & EHR Data AI Services
- Others
- Project-based AI Research Services
- Subscription-based AI Platforms (Service Mode)
- AI-as-a-Service (API / Cloud-based)
- Others
- Pharmaceutical & Biotech Companies
- CRO / CDMO-oriented Companies
- Academic & Research Institutes
- Others
- Abcellera Biologics
- Evotec
- Atomwise
- XtalPi
- PathAI
- Paige AI
- HotSpot Therapeutics
- Scorpion Therapeutics
- Charm Therapeutics
- LifeMine Therapeutics
- C4XD Discovery
- Wave Life Sciences
- Westlake Omics
- IIpharma
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe AI Biomedicine Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Biomedicine Service, with revenue, gross margin, and global market share of AI Biomedicine Service from 2021 to 2026.
Chapter 3, the AI Biomedicine Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Biomedicine Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Biomedicine Service.
Chapter 13, to describe AI Biomedicine Service research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Biomedicine Service by Type
1.3.1 Overview: Global AI Biomedicine Service Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global AI Biomedicine Service Consumption Value Market Share by Type in 2025
1.3.3 AI-driven Drug Discovery Services
1.3.4 AI-based Preclinical Research Services
1.3.5 AI-enabled Clinical Trial Services
1.3.6 AI Biomarker & Companion Diagnostic Services
1.3.7 Others
1.4 Classification of AI Biomedicine Service by Data Type & Modality
1.4.1 Overview: Global AI Biomedicine Service Market Size by Data Type & Modality: 2021 Versus 2025 Versus 2032
1.4.2 Global AI Biomedicine Service Consumption Value Market Share by Data Type & Modality in 2025
1.4.3 Genomics & Multi-omics AI Services
1.4.4 Medical Imaging & Digital Pathology AI Services
1.4.5 Chemical & Molecular Structure AI Services
1.4.6 Clinical & EHR Data AI Services
1.4.7 Others
1.5 Classification of AI Biomedicine Service by Service Delivery Model
1.5.1 Overview: Global AI Biomedicine Service Market Size by Service Delivery Model: 2021 Versus 2025 Versus 2032
1.5.2 Global AI Biomedicine Service Consumption Value Market Share by Service Delivery Model in 2025
1.5.3 Project-based AI Research Services
1.5.4 Subscription-based AI Platforms (Service Mode)
1.5.5 AI-as-a-Service (API / Cloud-based)
1.5.6 Others
1.6 Global AI Biomedicine Service Market by Application
1.6.1 Overview: Global AI Biomedicine Service Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Pharmaceutical & Biotech Companies
1.6.3 CRO / CDMO-oriented Companies
1.6.4 Academic & Research Institutes
1.6.5 Others
1.7 Global AI Biomedicine Service Market Size & Forecast
1.8 Global AI Biomedicine Service Market Size and Forecast by Region
1.8.1 Global AI Biomedicine Service Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global AI Biomedicine Service Market Size by Region, (2021-2032)
1.8.3 North America AI Biomedicine Service Market Size and Prospect (2021-2032)
1.8.4 Europe AI Biomedicine Service Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific AI Biomedicine Service Market Size and Prospect (2021-2032)
1.8.6 South America AI Biomedicine Service Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa AI Biomedicine Service Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Abcellera Biologics
2.1.1 Abcellera Biologics Details
2.1.2 Abcellera Biologics Major Business
2.1.3 Abcellera Biologics AI Biomedicine Service Product and Solutions
2.1.4 Abcellera Biologics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Abcellera Biologics Recent Developments and Future Plans
2.2 Evotec
2.2.1 Evotec Details
2.2.2 Evotec Major Business
2.2.3 Evotec AI Biomedicine Service Product and Solutions
2.2.4 Evotec AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Evotec Recent Developments and Future Plans
2.3 Atomwise
2.3.1 Atomwise Details
2.3.2 Atomwise Major Business
2.3.3 Atomwise AI Biomedicine Service Product and Solutions
2.3.4 Atomwise AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Atomwise Recent Developments and Future Plans
2.4 XtalPi
2.4.1 XtalPi Details
2.4.2 XtalPi Major Business
2.4.3 XtalPi AI Biomedicine Service Product and Solutions
2.4.4 XtalPi AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 XtalPi Recent Developments and Future Plans
2.5 PathAI
2.5.1 PathAI Details
2.5.2 PathAI Major Business
2.5.3 PathAI AI Biomedicine Service Product and Solutions
2.5.4 PathAI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 PathAI Recent Developments and Future Plans
2.6 Paige AI
2.6.1 Paige AI Details
2.6.2 Paige AI Major Business
2.6.3 Paige AI AI Biomedicine Service Product and Solutions
2.6.4 Paige AI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Paige AI Recent Developments and Future Plans
2.7 HotSpot Therapeutics
2.7.1 HotSpot Therapeutics Details
2.7.2 HotSpot Therapeutics Major Business
2.7.3 HotSpot Therapeutics AI Biomedicine Service Product and Solutions
2.7.4 HotSpot Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 HotSpot Therapeutics Recent Developments and Future Plans
2.8 Scorpion Therapeutics
2.8.1 Scorpion Therapeutics Details
2.8.2 Scorpion Therapeutics Major Business
2.8.3 Scorpion Therapeutics AI Biomedicine Service Product and Solutions
2.8.4 Scorpion Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Scorpion Therapeutics Recent Developments and Future Plans
2.9 Charm Therapeutics
2.9.1 Charm Therapeutics Details
2.9.2 Charm Therapeutics Major Business
2.9.3 Charm Therapeutics AI Biomedicine Service Product and Solutions
2.9.4 Charm Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Charm Therapeutics Recent Developments and Future Plans
2.10 LifeMine Therapeutics
2.10.1 LifeMine Therapeutics Details
2.10.2 LifeMine Therapeutics Major Business
2.10.3 LifeMine Therapeutics AI Biomedicine Service Product and Solutions
2.10.4 LifeMine Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 LifeMine Therapeutics Recent Developments and Future Plans
2.11 C4XD Discovery
2.11.1 C4XD Discovery Details
2.11.2 C4XD Discovery Major Business
2.11.3 C4XD Discovery AI Biomedicine Service Product and Solutions
2.11.4 C4XD Discovery AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 C4XD Discovery Recent Developments and Future Plans
2.12 Wave Life Sciences
2.12.1 Wave Life Sciences Details
2.12.2 Wave Life Sciences Major Business
2.12.3 Wave Life Sciences AI Biomedicine Service Product and Solutions
2.12.4 Wave Life Sciences AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Wave Life Sciences Recent Developments and Future Plans
2.13 Westlake Omics
2.13.1 Westlake Omics Details
2.13.2 Westlake Omics Major Business
2.13.3 Westlake Omics AI Biomedicine Service Product and Solutions
2.13.4 Westlake Omics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Westlake Omics Recent Developments and Future Plans
2.14 IIpharma
2.14.1 IIpharma Details
2.14.2 IIpharma Major Business
2.14.3 IIpharma AI Biomedicine Service Product and Solutions
2.14.4 IIpharma AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 IIpharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Biomedicine Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of AI Biomedicine Service by Company Revenue
3.2.2 Top 3 AI Biomedicine Service Players Market Share in 2025
3.2.3 Top 6 AI Biomedicine Service Players Market Share in 2025
3.3 AI Biomedicine Service Market: Overall Company Footprint Analysis
3.3.1 AI Biomedicine Service Market: Region Footprint
3.3.2 AI Biomedicine Service Market: Company Product Type Footprint
3.3.3 AI Biomedicine Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Biomedicine Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global AI Biomedicine Service Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Biomedicine Service Consumption Value Market Share by Application (2021-2026)
5.2 Global AI Biomedicine Service Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America AI Biomedicine Service Consumption Value by Type (2021-2032)
6.2 North America AI Biomedicine Service Market Size by Application (2021-2032)
6.3 North America AI Biomedicine Service Market Size by Country
6.3.1 North America AI Biomedicine Service Consumption Value by Country (2021-2032)
6.3.2 United States AI Biomedicine Service Market Size and Forecast (2021-2032)
6.3.3 Canada AI Biomedicine Service Market Size and Forecast (2021-2032)
6.3.4 Mexico AI Biomedicine Service Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe AI Biomedicine Service Consumption Value by Type (2021-2032)
7.2 Europe AI Biomedicine Service Consumption Value by Application (2021-2032)
7.3 Europe AI Biomedicine Service Market Size by Country
7.3.1 Europe AI Biomedicine Service Consumption Value by Country (2021-2032)
7.3.2 Germany AI Biomedicine Service Market Size and Forecast (2021-2032)
7.3.3 France AI Biomedicine Service Market Size and Forecast (2021-2032)
7.3.4 United Kingdom AI Biomedicine Service Market Size and Forecast (2021-2032)
7.3.5 Russia AI Biomedicine Service Market Size and Forecast (2021-2032)
7.3.6 Italy AI Biomedicine Service Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Biomedicine Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific AI Biomedicine Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific AI Biomedicine Service Market Size by Region
8.3.1 Asia-Pacific AI Biomedicine Service Consumption Value by Region (2021-2032)
8.3.2 China AI Biomedicine Service Market Size and Forecast (2021-2032)
8.3.3 Japan AI Biomedicine Service Market Size and Forecast (2021-2032)
8.3.4 South Korea AI Biomedicine Service Market Size and Forecast (2021-2032)
8.3.5 India AI Biomedicine Service Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia AI Biomedicine Service Market Size and Forecast (2021-2032)
8.3.7 Australia AI Biomedicine Service Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America AI Biomedicine Service Consumption Value by Type (2021-2032)
9.2 South America AI Biomedicine Service Consumption Value by Application (2021-2032)
9.3 South America AI Biomedicine Service Market Size by Country
9.3.1 South America AI Biomedicine Service Consumption Value by Country (2021-2032)
9.3.2 Brazil AI Biomedicine Service Market Size and Forecast (2021-2032)
9.3.3 Argentina AI Biomedicine Service Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Biomedicine Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa AI Biomedicine Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa AI Biomedicine Service Market Size by Country
10.3.1 Middle East & Africa AI Biomedicine Service Consumption Value by Country (2021-2032)
10.3.2 Turkey AI Biomedicine Service Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia AI Biomedicine Service Market Size and Forecast (2021-2032)
10.3.4 UAE AI Biomedicine Service Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 AI Biomedicine Service Market Drivers
11.2 AI Biomedicine Service Market Restraints
11.3 AI Biomedicine Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Biomedicine Service Industry Chain
12.2 AI Biomedicine Service Upstream Analysis
12.3 AI Biomedicine Service Midstream Analysis
12.4 AI Biomedicine Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Biomedicine Service by Type
1.3.1 Overview: Global AI Biomedicine Service Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global AI Biomedicine Service Consumption Value Market Share by Type in 2025
1.3.3 AI-driven Drug Discovery Services
1.3.4 AI-based Preclinical Research Services
1.3.5 AI-enabled Clinical Trial Services
1.3.6 AI Biomarker & Companion Diagnostic Services
1.3.7 Others
1.4 Classification of AI Biomedicine Service by Data Type & Modality
1.4.1 Overview: Global AI Biomedicine Service Market Size by Data Type & Modality: 2021 Versus 2025 Versus 2032
1.4.2 Global AI Biomedicine Service Consumption Value Market Share by Data Type & Modality in 2025
1.4.3 Genomics & Multi-omics AI Services
1.4.4 Medical Imaging & Digital Pathology AI Services
1.4.5 Chemical & Molecular Structure AI Services
1.4.6 Clinical & EHR Data AI Services
1.4.7 Others
1.5 Classification of AI Biomedicine Service by Service Delivery Model
1.5.1 Overview: Global AI Biomedicine Service Market Size by Service Delivery Model: 2021 Versus 2025 Versus 2032
1.5.2 Global AI Biomedicine Service Consumption Value Market Share by Service Delivery Model in 2025
1.5.3 Project-based AI Research Services
1.5.4 Subscription-based AI Platforms (Service Mode)
1.5.5 AI-as-a-Service (API / Cloud-based)
1.5.6 Others
1.6 Global AI Biomedicine Service Market by Application
1.6.1 Overview: Global AI Biomedicine Service Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Pharmaceutical & Biotech Companies
1.6.3 CRO / CDMO-oriented Companies
1.6.4 Academic & Research Institutes
1.6.5 Others
1.7 Global AI Biomedicine Service Market Size & Forecast
1.8 Global AI Biomedicine Service Market Size and Forecast by Region
1.8.1 Global AI Biomedicine Service Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global AI Biomedicine Service Market Size by Region, (2021-2032)
1.8.3 North America AI Biomedicine Service Market Size and Prospect (2021-2032)
1.8.4 Europe AI Biomedicine Service Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific AI Biomedicine Service Market Size and Prospect (2021-2032)
1.8.6 South America AI Biomedicine Service Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa AI Biomedicine Service Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Abcellera Biologics
2.1.1 Abcellera Biologics Details
2.1.2 Abcellera Biologics Major Business
2.1.3 Abcellera Biologics AI Biomedicine Service Product and Solutions
2.1.4 Abcellera Biologics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Abcellera Biologics Recent Developments and Future Plans
2.2 Evotec
2.2.1 Evotec Details
2.2.2 Evotec Major Business
2.2.3 Evotec AI Biomedicine Service Product and Solutions
2.2.4 Evotec AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Evotec Recent Developments and Future Plans
2.3 Atomwise
2.3.1 Atomwise Details
2.3.2 Atomwise Major Business
2.3.3 Atomwise AI Biomedicine Service Product and Solutions
2.3.4 Atomwise AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Atomwise Recent Developments and Future Plans
2.4 XtalPi
2.4.1 XtalPi Details
2.4.2 XtalPi Major Business
2.4.3 XtalPi AI Biomedicine Service Product and Solutions
2.4.4 XtalPi AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 XtalPi Recent Developments and Future Plans
2.5 PathAI
2.5.1 PathAI Details
2.5.2 PathAI Major Business
2.5.3 PathAI AI Biomedicine Service Product and Solutions
2.5.4 PathAI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 PathAI Recent Developments and Future Plans
2.6 Paige AI
2.6.1 Paige AI Details
2.6.2 Paige AI Major Business
2.6.3 Paige AI AI Biomedicine Service Product and Solutions
2.6.4 Paige AI AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Paige AI Recent Developments and Future Plans
2.7 HotSpot Therapeutics
2.7.1 HotSpot Therapeutics Details
2.7.2 HotSpot Therapeutics Major Business
2.7.3 HotSpot Therapeutics AI Biomedicine Service Product and Solutions
2.7.4 HotSpot Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 HotSpot Therapeutics Recent Developments and Future Plans
2.8 Scorpion Therapeutics
2.8.1 Scorpion Therapeutics Details
2.8.2 Scorpion Therapeutics Major Business
2.8.3 Scorpion Therapeutics AI Biomedicine Service Product and Solutions
2.8.4 Scorpion Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Scorpion Therapeutics Recent Developments and Future Plans
2.9 Charm Therapeutics
2.9.1 Charm Therapeutics Details
2.9.2 Charm Therapeutics Major Business
2.9.3 Charm Therapeutics AI Biomedicine Service Product and Solutions
2.9.4 Charm Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Charm Therapeutics Recent Developments and Future Plans
2.10 LifeMine Therapeutics
2.10.1 LifeMine Therapeutics Details
2.10.2 LifeMine Therapeutics Major Business
2.10.3 LifeMine Therapeutics AI Biomedicine Service Product and Solutions
2.10.4 LifeMine Therapeutics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 LifeMine Therapeutics Recent Developments and Future Plans
2.11 C4XD Discovery
2.11.1 C4XD Discovery Details
2.11.2 C4XD Discovery Major Business
2.11.3 C4XD Discovery AI Biomedicine Service Product and Solutions
2.11.4 C4XD Discovery AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 C4XD Discovery Recent Developments and Future Plans
2.12 Wave Life Sciences
2.12.1 Wave Life Sciences Details
2.12.2 Wave Life Sciences Major Business
2.12.3 Wave Life Sciences AI Biomedicine Service Product and Solutions
2.12.4 Wave Life Sciences AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Wave Life Sciences Recent Developments and Future Plans
2.13 Westlake Omics
2.13.1 Westlake Omics Details
2.13.2 Westlake Omics Major Business
2.13.3 Westlake Omics AI Biomedicine Service Product and Solutions
2.13.4 Westlake Omics AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Westlake Omics Recent Developments and Future Plans
2.14 IIpharma
2.14.1 IIpharma Details
2.14.2 IIpharma Major Business
2.14.3 IIpharma AI Biomedicine Service Product and Solutions
2.14.4 IIpharma AI Biomedicine Service Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 IIpharma Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Biomedicine Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of AI Biomedicine Service by Company Revenue
3.2.2 Top 3 AI Biomedicine Service Players Market Share in 2025
3.2.3 Top 6 AI Biomedicine Service Players Market Share in 2025
3.3 AI Biomedicine Service Market: Overall Company Footprint Analysis
3.3.1 AI Biomedicine Service Market: Region Footprint
3.3.2 AI Biomedicine Service Market: Company Product Type Footprint
3.3.3 AI Biomedicine Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Biomedicine Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global AI Biomedicine Service Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Biomedicine Service Consumption Value Market Share by Application (2021-2026)
5.2 Global AI Biomedicine Service Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America AI Biomedicine Service Consumption Value by Type (2021-2032)
6.2 North America AI Biomedicine Service Market Size by Application (2021-2032)
6.3 North America AI Biomedicine Service Market Size by Country
6.3.1 North America AI Biomedicine Service Consumption Value by Country (2021-2032)
6.3.2 United States AI Biomedicine Service Market Size and Forecast (2021-2032)
6.3.3 Canada AI Biomedicine Service Market Size and Forecast (2021-2032)
6.3.4 Mexico AI Biomedicine Service Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe AI Biomedicine Service Consumption Value by Type (2021-2032)
7.2 Europe AI Biomedicine Service Consumption Value by Application (2021-2032)
7.3 Europe AI Biomedicine Service Market Size by Country
7.3.1 Europe AI Biomedicine Service Consumption Value by Country (2021-2032)
7.3.2 Germany AI Biomedicine Service Market Size and Forecast (2021-2032)
7.3.3 France AI Biomedicine Service Market Size and Forecast (2021-2032)
7.3.4 United Kingdom AI Biomedicine Service Market Size and Forecast (2021-2032)
7.3.5 Russia AI Biomedicine Service Market Size and Forecast (2021-2032)
7.3.6 Italy AI Biomedicine Service Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Biomedicine Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific AI Biomedicine Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific AI Biomedicine Service Market Size by Region
8.3.1 Asia-Pacific AI Biomedicine Service Consumption Value by Region (2021-2032)
8.3.2 China AI Biomedicine Service Market Size and Forecast (2021-2032)
8.3.3 Japan AI Biomedicine Service Market Size and Forecast (2021-2032)
8.3.4 South Korea AI Biomedicine Service Market Size and Forecast (2021-2032)
8.3.5 India AI Biomedicine Service Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia AI Biomedicine Service Market Size and Forecast (2021-2032)
8.3.7 Australia AI Biomedicine Service Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America AI Biomedicine Service Consumption Value by Type (2021-2032)
9.2 South America AI Biomedicine Service Consumption Value by Application (2021-2032)
9.3 South America AI Biomedicine Service Market Size by Country
9.3.1 South America AI Biomedicine Service Consumption Value by Country (2021-2032)
9.3.2 Brazil AI Biomedicine Service Market Size and Forecast (2021-2032)
9.3.3 Argentina AI Biomedicine Service Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Biomedicine Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa AI Biomedicine Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa AI Biomedicine Service Market Size by Country
10.3.1 Middle East & Africa AI Biomedicine Service Consumption Value by Country (2021-2032)
10.3.2 Turkey AI Biomedicine Service Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia AI Biomedicine Service Market Size and Forecast (2021-2032)
10.3.4 UAE AI Biomedicine Service Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 AI Biomedicine Service Market Drivers
11.2 AI Biomedicine Service Market Restraints
11.3 AI Biomedicine Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Biomedicine Service Industry Chain
12.2 AI Biomedicine Service Upstream Analysis
12.3 AI Biomedicine Service Midstream Analysis
12.4 AI Biomedicine Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global AI Biomedicine Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global AI Biomedicine Service Consumption Value by Data Type & Modality, (USD Million), 2021 & 2025 & 2032
Table 3. Global AI Biomedicine Service Consumption Value by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Table 4. Global AI Biomedicine Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global AI Biomedicine Service Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global AI Biomedicine Service Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Abcellera Biologics Company Information, Head Office, and Major Competitors
Table 8. Abcellera Biologics Major Business
Table 9. Abcellera Biologics AI Biomedicine Service Product and Solutions
Table 10. Abcellera Biologics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Abcellera Biologics Recent Developments and Future Plans
Table 12. Evotec Company Information, Head Office, and Major Competitors
Table 13. Evotec Major Business
Table 14. Evotec AI Biomedicine Service Product and Solutions
Table 15. Evotec AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Evotec Recent Developments and Future Plans
Table 17. Atomwise Company Information, Head Office, and Major Competitors
Table 18. Atomwise Major Business
Table 19. Atomwise AI Biomedicine Service Product and Solutions
Table 20. Atomwise AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. XtalPi Company Information, Head Office, and Major Competitors
Table 22. XtalPi Major Business
Table 23. XtalPi AI Biomedicine Service Product and Solutions
Table 24. XtalPi AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. XtalPi Recent Developments and Future Plans
Table 26. PathAI Company Information, Head Office, and Major Competitors
Table 27. PathAI Major Business
Table 28. PathAI AI Biomedicine Service Product and Solutions
Table 29. PathAI AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. PathAI Recent Developments and Future Plans
Table 31. Paige AI Company Information, Head Office, and Major Competitors
Table 32. Paige AI Major Business
Table 33. Paige AI AI Biomedicine Service Product and Solutions
Table 34. Paige AI AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Paige AI Recent Developments and Future Plans
Table 36. HotSpot Therapeutics Company Information, Head Office, and Major Competitors
Table 37. HotSpot Therapeutics Major Business
Table 38. HotSpot Therapeutics AI Biomedicine Service Product and Solutions
Table 39. HotSpot Therapeutics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. HotSpot Therapeutics Recent Developments and Future Plans
Table 41. Scorpion Therapeutics Company Information, Head Office, and Major Competitors
Table 42. Scorpion Therapeutics Major Business
Table 43. Scorpion Therapeutics AI Biomedicine Service Product and Solutions
Table 44. Scorpion Therapeutics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Scorpion Therapeutics Recent Developments and Future Plans
Table 46. Charm Therapeutics Company Information, Head Office, and Major Competitors
Table 47. Charm Therapeutics Major Business
Table 48. Charm Therapeutics AI Biomedicine Service Product and Solutions
Table 49. Charm Therapeutics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Charm Therapeutics Recent Developments and Future Plans
Table 51. LifeMine Therapeutics Company Information, Head Office, and Major Competitors
Table 52. LifeMine Therapeutics Major Business
Table 53. LifeMine Therapeutics AI Biomedicine Service Product and Solutions
Table 54. LifeMine Therapeutics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. LifeMine Therapeutics Recent Developments and Future Plans
Table 56. C4XD Discovery Company Information, Head Office, and Major Competitors
Table 57. C4XD Discovery Major Business
Table 58. C4XD Discovery AI Biomedicine Service Product and Solutions
Table 59. C4XD Discovery AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. C4XD Discovery Recent Developments and Future Plans
Table 61. Wave Life Sciences Company Information, Head Office, and Major Competitors
Table 62. Wave Life Sciences Major Business
Table 63. Wave Life Sciences AI Biomedicine Service Product and Solutions
Table 64. Wave Life Sciences AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Wave Life Sciences Recent Developments and Future Plans
Table 66. Westlake Omics Company Information, Head Office, and Major Competitors
Table 67. Westlake Omics Major Business
Table 68. Westlake Omics AI Biomedicine Service Product and Solutions
Table 69. Westlake Omics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Westlake Omics Recent Developments and Future Plans
Table 71. IIpharma Company Information, Head Office, and Major Competitors
Table 72. IIpharma Major Business
Table 73. IIpharma AI Biomedicine Service Product and Solutions
Table 74. IIpharma AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. IIpharma Recent Developments and Future Plans
Table 76. Global AI Biomedicine Service Revenue (USD Million) by Players (2021-2026)
Table 77. Global AI Biomedicine Service Revenue Share by Players (2021-2026)
Table 78. Breakdown of AI Biomedicine Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 79. Market Position of Players in AI Biomedicine Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 80. Head Office of Key AI Biomedicine Service Players
Table 81. AI Biomedicine Service Market: Company Product Type Footprint
Table 82. AI Biomedicine Service Market: Company Product Application Footprint
Table 83. AI Biomedicine Service New Market Entrants and Barriers to Market Entry
Table 84. AI Biomedicine Service Mergers, Acquisition, Agreements, and Collaborations
Table 85. Global AI Biomedicine Service Consumption Value (USD Million) by Type (2021-2026)
Table 86. Global AI Biomedicine Service Consumption Value Share by Type (2021-2026)
Table 87. Global AI Biomedicine Service Consumption Value Forecast by Type (2027-2032)
Table 88. Global AI Biomedicine Service Consumption Value by Application (2021-2026)
Table 89. Global AI Biomedicine Service Consumption Value Forecast by Application (2027-2032)
Table 90. North America AI Biomedicine Service Consumption Value by Type (2021-2026) & (USD Million)
Table 91. North America AI Biomedicine Service Consumption Value by Type (2027-2032) & (USD Million)
Table 92. North America AI Biomedicine Service Consumption Value by Application (2021-2026) & (USD Million)
Table 93. North America AI Biomedicine Service Consumption Value by Application (2027-2032) & (USD Million)
Table 94. North America AI Biomedicine Service Consumption Value by Country (2021-2026) & (USD Million)
Table 95. North America AI Biomedicine Service Consumption Value by Country (2027-2032) & (USD Million)
Table 96. Europe AI Biomedicine Service Consumption Value by Type (2021-2026) & (USD Million)
Table 97. Europe AI Biomedicine Service Consumption Value by Type (2027-2032) & (USD Million)
Table 98. Europe AI Biomedicine Service Consumption Value by Application (2021-2026) & (USD Million)
Table 99. Europe AI Biomedicine Service Consumption Value by Application (2027-2032) & (USD Million)
Table 100. Europe AI Biomedicine Service Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe AI Biomedicine Service Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific AI Biomedicine Service Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific AI Biomedicine Service Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Asia-Pacific AI Biomedicine Service Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific AI Biomedicine Service Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Asia-Pacific AI Biomedicine Service Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Asia-Pacific AI Biomedicine Service Consumption Value by Region (2027-2032) & (USD Million)
Table 108. South America AI Biomedicine Service Consumption Value by Type (2021-2026) & (USD Million)
Table 109. South America AI Biomedicine Service Consumption Value by Type (2027-2032) & (USD Million)
Table 110. South America AI Biomedicine Service Consumption Value by Application (2021-2026) & (USD Million)
Table 111. South America AI Biomedicine Service Consumption Value by Application (2027-2032) & (USD Million)
Table 112. South America AI Biomedicine Service Consumption Value by Country (2021-2026) & (USD Million)
Table 113. South America AI Biomedicine Service Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Middle East & Africa AI Biomedicine Service Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa AI Biomedicine Service Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Middle East & Africa AI Biomedicine Service Consumption Value by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa AI Biomedicine Service Consumption Value by Application (2027-2032) & (USD Million)
Table 118. Middle East & Africa AI Biomedicine Service Consumption Value by Country (2021-2026) & (USD Million)
Table 119. Middle East & Africa AI Biomedicine Service Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Global Key Players of AI Biomedicine Service Upstream (Raw Materials)
Table 121. Global AI Biomedicine Service Typical Customers
Table 1. Global AI Biomedicine Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global AI Biomedicine Service Consumption Value by Data Type & Modality, (USD Million), 2021 & 2025 & 2032
Table 3. Global AI Biomedicine Service Consumption Value by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Table 4. Global AI Biomedicine Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global AI Biomedicine Service Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global AI Biomedicine Service Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Abcellera Biologics Company Information, Head Office, and Major Competitors
Table 8. Abcellera Biologics Major Business
Table 9. Abcellera Biologics AI Biomedicine Service Product and Solutions
Table 10. Abcellera Biologics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Abcellera Biologics Recent Developments and Future Plans
Table 12. Evotec Company Information, Head Office, and Major Competitors
Table 13. Evotec Major Business
Table 14. Evotec AI Biomedicine Service Product and Solutions
Table 15. Evotec AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Evotec Recent Developments and Future Plans
Table 17. Atomwise Company Information, Head Office, and Major Competitors
Table 18. Atomwise Major Business
Table 19. Atomwise AI Biomedicine Service Product and Solutions
Table 20. Atomwise AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. XtalPi Company Information, Head Office, and Major Competitors
Table 22. XtalPi Major Business
Table 23. XtalPi AI Biomedicine Service Product and Solutions
Table 24. XtalPi AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. XtalPi Recent Developments and Future Plans
Table 26. PathAI Company Information, Head Office, and Major Competitors
Table 27. PathAI Major Business
Table 28. PathAI AI Biomedicine Service Product and Solutions
Table 29. PathAI AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. PathAI Recent Developments and Future Plans
Table 31. Paige AI Company Information, Head Office, and Major Competitors
Table 32. Paige AI Major Business
Table 33. Paige AI AI Biomedicine Service Product and Solutions
Table 34. Paige AI AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Paige AI Recent Developments and Future Plans
Table 36. HotSpot Therapeutics Company Information, Head Office, and Major Competitors
Table 37. HotSpot Therapeutics Major Business
Table 38. HotSpot Therapeutics AI Biomedicine Service Product and Solutions
Table 39. HotSpot Therapeutics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. HotSpot Therapeutics Recent Developments and Future Plans
Table 41. Scorpion Therapeutics Company Information, Head Office, and Major Competitors
Table 42. Scorpion Therapeutics Major Business
Table 43. Scorpion Therapeutics AI Biomedicine Service Product and Solutions
Table 44. Scorpion Therapeutics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Scorpion Therapeutics Recent Developments and Future Plans
Table 46. Charm Therapeutics Company Information, Head Office, and Major Competitors
Table 47. Charm Therapeutics Major Business
Table 48. Charm Therapeutics AI Biomedicine Service Product and Solutions
Table 49. Charm Therapeutics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Charm Therapeutics Recent Developments and Future Plans
Table 51. LifeMine Therapeutics Company Information, Head Office, and Major Competitors
Table 52. LifeMine Therapeutics Major Business
Table 53. LifeMine Therapeutics AI Biomedicine Service Product and Solutions
Table 54. LifeMine Therapeutics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. LifeMine Therapeutics Recent Developments and Future Plans
Table 56. C4XD Discovery Company Information, Head Office, and Major Competitors
Table 57. C4XD Discovery Major Business
Table 58. C4XD Discovery AI Biomedicine Service Product and Solutions
Table 59. C4XD Discovery AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. C4XD Discovery Recent Developments and Future Plans
Table 61. Wave Life Sciences Company Information, Head Office, and Major Competitors
Table 62. Wave Life Sciences Major Business
Table 63. Wave Life Sciences AI Biomedicine Service Product and Solutions
Table 64. Wave Life Sciences AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Wave Life Sciences Recent Developments and Future Plans
Table 66. Westlake Omics Company Information, Head Office, and Major Competitors
Table 67. Westlake Omics Major Business
Table 68. Westlake Omics AI Biomedicine Service Product and Solutions
Table 69. Westlake Omics AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Westlake Omics Recent Developments and Future Plans
Table 71. IIpharma Company Information, Head Office, and Major Competitors
Table 72. IIpharma Major Business
Table 73. IIpharma AI Biomedicine Service Product and Solutions
Table 74. IIpharma AI Biomedicine Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. IIpharma Recent Developments and Future Plans
Table 76. Global AI Biomedicine Service Revenue (USD Million) by Players (2021-2026)
Table 77. Global AI Biomedicine Service Revenue Share by Players (2021-2026)
Table 78. Breakdown of AI Biomedicine Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 79. Market Position of Players in AI Biomedicine Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 80. Head Office of Key AI Biomedicine Service Players
Table 81. AI Biomedicine Service Market: Company Product Type Footprint
Table 82. AI Biomedicine Service Market: Company Product Application Footprint
Table 83. AI Biomedicine Service New Market Entrants and Barriers to Market Entry
Table 84. AI Biomedicine Service Mergers, Acquisition, Agreements, and Collaborations
Table 85. Global AI Biomedicine Service Consumption Value (USD Million) by Type (2021-2026)
Table 86. Global AI Biomedicine Service Consumption Value Share by Type (2021-2026)
Table 87. Global AI Biomedicine Service Consumption Value Forecast by Type (2027-2032)
Table 88. Global AI Biomedicine Service Consumption Value by Application (2021-2026)
Table 89. Global AI Biomedicine Service Consumption Value Forecast by Application (2027-2032)
Table 90. North America AI Biomedicine Service Consumption Value by Type (2021-2026) & (USD Million)
Table 91. North America AI Biomedicine Service Consumption Value by Type (2027-2032) & (USD Million)
Table 92. North America AI Biomedicine Service Consumption Value by Application (2021-2026) & (USD Million)
Table 93. North America AI Biomedicine Service Consumption Value by Application (2027-2032) & (USD Million)
Table 94. North America AI Biomedicine Service Consumption Value by Country (2021-2026) & (USD Million)
Table 95. North America AI Biomedicine Service Consumption Value by Country (2027-2032) & (USD Million)
Table 96. Europe AI Biomedicine Service Consumption Value by Type (2021-2026) & (USD Million)
Table 97. Europe AI Biomedicine Service Consumption Value by Type (2027-2032) & (USD Million)
Table 98. Europe AI Biomedicine Service Consumption Value by Application (2021-2026) & (USD Million)
Table 99. Europe AI Biomedicine Service Consumption Value by Application (2027-2032) & (USD Million)
Table 100. Europe AI Biomedicine Service Consumption Value by Country (2021-2026) & (USD Million)
Table 101. Europe AI Biomedicine Service Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Asia-Pacific AI Biomedicine Service Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Asia-Pacific AI Biomedicine Service Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Asia-Pacific AI Biomedicine Service Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Asia-Pacific AI Biomedicine Service Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Asia-Pacific AI Biomedicine Service Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Asia-Pacific AI Biomedicine Service Consumption Value by Region (2027-2032) & (USD Million)
Table 108. South America AI Biomedicine Service Consumption Value by Type (2021-2026) & (USD Million)
Table 109. South America AI Biomedicine Service Consumption Value by Type (2027-2032) & (USD Million)
Table 110. South America AI Biomedicine Service Consumption Value by Application (2021-2026) & (USD Million)
Table 111. South America AI Biomedicine Service Consumption Value by Application (2027-2032) & (USD Million)
Table 112. South America AI Biomedicine Service Consumption Value by Country (2021-2026) & (USD Million)
Table 113. South America AI Biomedicine Service Consumption Value by Country (2027-2032) & (USD Million)
Table 114. Middle East & Africa AI Biomedicine Service Consumption Value by Type (2021-2026) & (USD Million)
Table 115. Middle East & Africa AI Biomedicine Service Consumption Value by Type (2027-2032) & (USD Million)
Table 116. Middle East & Africa AI Biomedicine Service Consumption Value by Application (2021-2026) & (USD Million)
Table 117. Middle East & Africa AI Biomedicine Service Consumption Value by Application (2027-2032) & (USD Million)
Table 118. Middle East & Africa AI Biomedicine Service Consumption Value by Country (2021-2026) & (USD Million)
Table 119. Middle East & Africa AI Biomedicine Service Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Global Key Players of AI Biomedicine Service Upstream (Raw Materials)
Table 121. Global AI Biomedicine Service Typical Customers
LIST OF FIGURES
Figure 1. AI Biomedicine Service Picture
Figure 2. Global AI Biomedicine Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global AI Biomedicine Service Consumption Value Market Share by Type in 2025
Figure 4. AI-driven Drug Discovery Services
Figure 5. AI-based Preclinical Research Services
Figure 6. AI-enabled Clinical Trial Services
Figure 7. AI Biomarker & Companion Diagnostic Services
Figure 8. Others
Figure 9. Global AI Biomedicine Service Consumption Value by Data Type & Modality, (USD Million), 2021 & 2025 & 2032
Figure 10. Global AI Biomedicine Service Consumption Value Market Share by Data Type & Modality in 2025
Figure 11. Genomics & Multi-omics AI Services
Figure 12. Medical Imaging & Digital Pathology AI Services
Figure 13. Chemical & Molecular Structure AI Services
Figure 14. Clinical & EHR Data AI Services
Figure 15. Others
Figure 16. Global AI Biomedicine Service Consumption Value by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Figure 17. Global AI Biomedicine Service Consumption Value Market Share by Service Delivery Model in 2025
Figure 18. Project-based AI Research Services
Figure 19. Subscription-based AI Platforms (Service Mode)
Figure 20. AI-as-a-Service (API / Cloud-based)
Figure 21. Others
Figure 22. Global AI Biomedicine Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 23. AI Biomedicine Service Consumption Value Market Share by Application in 2025
Figure 24. Pharmaceutical & Biotech Companies Picture
Figure 25. CRO / CDMO-oriented Companies Picture
Figure 26. Academic & Research Institutes Picture
Figure 27. Others Picture
Figure 28. Global AI Biomedicine Service Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 29. Global AI Biomedicine Service Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 30. Global Market AI Biomedicine Service Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 31. Global AI Biomedicine Service Consumption Value Market Share by Region (2021-2032)
Figure 32. Global AI Biomedicine Service Consumption Value Market Share by Region in 2025
Figure 33. North America AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 36. South America AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 38. Company Three Recent Developments and Future Plans
Figure 39. Global AI Biomedicine Service Revenue Share by Players in 2025
Figure 40. AI Biomedicine Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 41. Market Share of AI Biomedicine Service by Player Revenue in 2025
Figure 42. Top 3 AI Biomedicine Service Players Market Share in 2025
Figure 43. Top 6 AI Biomedicine Service Players Market Share in 2025
Figure 44. Global AI Biomedicine Service Consumption Value Share by Type (2021-2026)
Figure 45. Global AI Biomedicine Service Market Share Forecast by Type (2027-2032)
Figure 46. Global AI Biomedicine Service Consumption Value Share by Application (2021-2026)
Figure 47. Global AI Biomedicine Service Market Share Forecast by Application (2027-2032)
Figure 48. North America AI Biomedicine Service Consumption Value Market Share by Type (2021-2032)
Figure 49. North America AI Biomedicine Service Consumption Value Market Share by Application (2021-2032)
Figure 50. North America AI Biomedicine Service Consumption Value Market Share by Country (2021-2032)
Figure 51. United States AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 52. Canada AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 53. Mexico AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 54. Europe AI Biomedicine Service Consumption Value Market Share by Type (2021-2032)
Figure 55. Europe AI Biomedicine Service Consumption Value Market Share by Application (2021-2032)
Figure 56. Europe AI Biomedicine Service Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 58. France AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific AI Biomedicine Service Consumption Value Market Share by Type (2021-2032)
Figure 63. Asia-Pacific AI Biomedicine Service Consumption Value Market Share by Application (2021-2032)
Figure 64. Asia-Pacific AI Biomedicine Service Consumption Value Market Share by Region (2021-2032)
Figure 65. China AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 66. Japan AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 67. South Korea AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 68. India AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 69. Southeast Asia AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 70. Australia AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 71. South America AI Biomedicine Service Consumption Value Market Share by Type (2021-2032)
Figure 72. South America AI Biomedicine Service Consumption Value Market Share by Application (2021-2032)
Figure 73. South America AI Biomedicine Service Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa AI Biomedicine Service Consumption Value Market Share by Type (2021-2032)
Figure 77. Middle East & Africa AI Biomedicine Service Consumption Value Market Share by Application (2021-2032)
Figure 78. Middle East & Africa AI Biomedicine Service Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 81. UAE AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 82. AI Biomedicine Service Market Drivers
Figure 83. AI Biomedicine Service Market Restraints
Figure 84. AI Biomedicine Service Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. AI Biomedicine Service Industrial Chain
Figure 87. Methodology
Figure 88. Research Process and Data Source
Figure 1. AI Biomedicine Service Picture
Figure 2. Global AI Biomedicine Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global AI Biomedicine Service Consumption Value Market Share by Type in 2025
Figure 4. AI-driven Drug Discovery Services
Figure 5. AI-based Preclinical Research Services
Figure 6. AI-enabled Clinical Trial Services
Figure 7. AI Biomarker & Companion Diagnostic Services
Figure 8. Others
Figure 9. Global AI Biomedicine Service Consumption Value by Data Type & Modality, (USD Million), 2021 & 2025 & 2032
Figure 10. Global AI Biomedicine Service Consumption Value Market Share by Data Type & Modality in 2025
Figure 11. Genomics & Multi-omics AI Services
Figure 12. Medical Imaging & Digital Pathology AI Services
Figure 13. Chemical & Molecular Structure AI Services
Figure 14. Clinical & EHR Data AI Services
Figure 15. Others
Figure 16. Global AI Biomedicine Service Consumption Value by Service Delivery Model, (USD Million), 2021 & 2025 & 2032
Figure 17. Global AI Biomedicine Service Consumption Value Market Share by Service Delivery Model in 2025
Figure 18. Project-based AI Research Services
Figure 19. Subscription-based AI Platforms (Service Mode)
Figure 20. AI-as-a-Service (API / Cloud-based)
Figure 21. Others
Figure 22. Global AI Biomedicine Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 23. AI Biomedicine Service Consumption Value Market Share by Application in 2025
Figure 24. Pharmaceutical & Biotech Companies Picture
Figure 25. CRO / CDMO-oriented Companies Picture
Figure 26. Academic & Research Institutes Picture
Figure 27. Others Picture
Figure 28. Global AI Biomedicine Service Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 29. Global AI Biomedicine Service Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 30. Global Market AI Biomedicine Service Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 31. Global AI Biomedicine Service Consumption Value Market Share by Region (2021-2032)
Figure 32. Global AI Biomedicine Service Consumption Value Market Share by Region in 2025
Figure 33. North America AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 36. South America AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 38. Company Three Recent Developments and Future Plans
Figure 39. Global AI Biomedicine Service Revenue Share by Players in 2025
Figure 40. AI Biomedicine Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 41. Market Share of AI Biomedicine Service by Player Revenue in 2025
Figure 42. Top 3 AI Biomedicine Service Players Market Share in 2025
Figure 43. Top 6 AI Biomedicine Service Players Market Share in 2025
Figure 44. Global AI Biomedicine Service Consumption Value Share by Type (2021-2026)
Figure 45. Global AI Biomedicine Service Market Share Forecast by Type (2027-2032)
Figure 46. Global AI Biomedicine Service Consumption Value Share by Application (2021-2026)
Figure 47. Global AI Biomedicine Service Market Share Forecast by Application (2027-2032)
Figure 48. North America AI Biomedicine Service Consumption Value Market Share by Type (2021-2032)
Figure 49. North America AI Biomedicine Service Consumption Value Market Share by Application (2021-2032)
Figure 50. North America AI Biomedicine Service Consumption Value Market Share by Country (2021-2032)
Figure 51. United States AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 52. Canada AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 53. Mexico AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 54. Europe AI Biomedicine Service Consumption Value Market Share by Type (2021-2032)
Figure 55. Europe AI Biomedicine Service Consumption Value Market Share by Application (2021-2032)
Figure 56. Europe AI Biomedicine Service Consumption Value Market Share by Country (2021-2032)
Figure 57. Germany AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 58. France AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 59. United Kingdom AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 60. Russia AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 61. Italy AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 62. Asia-Pacific AI Biomedicine Service Consumption Value Market Share by Type (2021-2032)
Figure 63. Asia-Pacific AI Biomedicine Service Consumption Value Market Share by Application (2021-2032)
Figure 64. Asia-Pacific AI Biomedicine Service Consumption Value Market Share by Region (2021-2032)
Figure 65. China AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 66. Japan AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 67. South Korea AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 68. India AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 69. Southeast Asia AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 70. Australia AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 71. South America AI Biomedicine Service Consumption Value Market Share by Type (2021-2032)
Figure 72. South America AI Biomedicine Service Consumption Value Market Share by Application (2021-2032)
Figure 73. South America AI Biomedicine Service Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa AI Biomedicine Service Consumption Value Market Share by Type (2021-2032)
Figure 77. Middle East & Africa AI Biomedicine Service Consumption Value Market Share by Application (2021-2032)
Figure 78. Middle East & Africa AI Biomedicine Service Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 80. Saudi Arabia AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 81. UAE AI Biomedicine Service Consumption Value (2021-2032) & (USD Million)
Figure 82. AI Biomedicine Service Market Drivers
Figure 83. AI Biomedicine Service Market Restraints
Figure 84. AI Biomedicine Service Market Trends
Figure 85. Porters Five Forces Analysis
Figure 86. AI Biomedicine Service Industrial Chain
Figure 87. Methodology
Figure 88. Research Process and Data Source
